UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000039594
Receipt No. R000045020
Scientific Title The study of hypoxia imaging using FAZA(1-(5-[18 F]Fluoro-5-deoxy-alpha-D-arabinofuranosyl)-2-nitroimidazole)
Date of disclosure of the study information 2020/04/01
Last modified on 2020/04/16 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The study of hypoxia imaging using FAZA
Acronym Hypoxia imaging with FAZA
Scientific Title The study of hypoxia imaging using FAZA(1-(5-[18 F]Fluoro-5-deoxy-alpha-D-arabinofuranosyl)-2-nitroimidazole)
Scientific Title:Acronym The study of hypoxia imaging using FAZA
Region
Japan

Condition
Condition ischemic disease, malignant tumor
Classification by specialty
Medicine in general Surgery in general Neurosurgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate clinical usefulness of hypoxia imaging using [F-18] FAZA PET/CT for patients with ischemic disease ore malignant tumors.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the uptake of [F-18] FAZA in lesions
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Medicine
Interventions/Control_1 FAZA PET/CT
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Assured for (F-18) FDG PET/CT, greater than or
equal to 20 year of age with written informed
consent
Key exclusion criteria 1.The case who is difficult to participate in the study due to psychological disorders and other diseases.
2.The case who is judged as inappropriate by the physician
Target sample size 30

Research contact person
Name of lead principal investigator
1st name Ukihide
Middle name
Last name Tateishi
Organization Medical Hospital Tokyo Medical and De
ntal University
Division name Department of Diagnostic Radiology
Zip code 1138519
Address 1-5-45 Yushima,Bunkyo-ku,Tokyo
TEL 03-5803-5311
Email ttisdrnm@tmd.ac.jp

Public contact
Name of contact person
1st name Junichi
Middle name
Last name Tsuchiya
Organization Medical Hospital Tokyo Medical and Dental University
Division name Department of Diagnostic Radiology
Zip code 1138519
Address 1-5-45 Yushima,Bunkyo-ku,Tokyo
TEL 03-5803-5311
Homepage URL
Email tcymrad@tmd.ac.jp

Sponsor
Institute Department of Diagnostic Radiology,Medical Hospital Tokyo Medical and Dental University
Institute
Department

Funding Source
Organization Department of Diagnostic Radiology,M
edical Hospital Tokyo Medical and Dent
al University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Life Sciences and Bioethics, Tokyo Medical and Dental University
Address 1-5-45 Yushima,Bunkyo-ku,Tokyo
Tel 03-5803-4724
Email info.bec@tmd.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 04 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 04 Month 01 Day
Date of IRB
Anticipated trial start date
2020 Year 04 Month 01 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 02 Month 25 Day
Last modified on
2020 Year 04 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045020